We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

9961:HKEXTrip.com Group Ltd. Analysis

Data as of 2026-09-08 - not real-time

HK$324.20

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind Trip.com Group Limited is neutral at HKD 324.20, with no clear ordering between short and long averages. The last 30 days have lost 7.2%. Relative strength is 33.7 — approaching oversold — and the MACD signal is bearish. The recent range runs from support at HKD 322.00 up to resistance at HKD 368.00.
Multiples put this in undervalued territory at a P/E of 6.1. Analyst price targets sit 46.8% above the current price. Revenue is growing at 17.2% on a 48.6% profit margin. The 0.58% dividend yield looks covered by current payout levels.
The composite risk read is 5/10, putting it in moderate territory. With 30-day volatility of 30.4%, a beta of 0.47 and a maximum drawdown of 49.9%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Near-term and long-term part ways here — hold short-term against buy longer out, with 6/10 conviction on the long call.

Top Market Events

Updated May 27, 2026 0 SINGAPORE, May 27, 2026 /PRNewswire/ -- Trip.The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting...Updated Jun 11, 2026 0 SINGAPORE, June 11, 2026 /PRNewswire/ -- Trip.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Trading below the 200-day average of 424.14
  • MACD momentum is negative
  • 30-day price change of -7.2%

Medium Term

1–3 years
Positive
Model confidence: 4/10

Key Factors

  • Trading below the 200-day average of 424.14
  • Analyst targets imply +46.8% versus the current price
  • MACD momentum is negative

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Analyst targets imply +46.8% versus the current price
  • Profit margin of 48.6% is healthy
  • Revenue growth of +17.2%

Key Metrics & Analysis

Financial Health

Revenue Growth17.20%
Profit Margin48.65%
P/E Ratio6.1
ROE20.14%
ROA3.95%
Debt/Equity18.82
P/B Ratio1.1

Technical Analysis

TrendNeutral
RSI33.7
SupportHK$322.00
ResistanceHK$368.00
MA 20HK$348.86
MA 50HK$346.27
MA 200HK$424.14
MACDBearish
VolumeIncreasing
Fear & Greed Index93.66

Valuation

Target PriceHK$475.93
Upside/Downside46.80%
GradeUndervalued
TypeBlend
Dividend Yield0.58%

Risk Assessment

Beta0.47
Volatility30.44%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.